MoneyWorks4Me

Lasa Supergenerics informs about outcome of EGM

22 Feb 2025 Evaluate
Pursuant to Regulation 30 of the Securities and Exchange Board of India (Listing Obligation and Disclosure Requirements) Regulations 2015, as amended, Lasa Supergenerics has submitted the summary of proceedings of the Extra - ordinary General Meeting of the Company held on Saturday, 22nd February, 2025 at 09:30 AM Indian Standard Time (IST), concluded at 09:53 AM through Video Conferencing/ Other Audio Visual Means (VC/OAVM). The Meeting was held in compliance with the General Circulars issued by the Ministry of Corporate Affairs (MCA) and Circular issued by the Securities and Exchange Board of India (SEBI) and as per the applicable provisions of the Companies Act, 2013 and the Rules made thereunder. Further pursuant to Regulation 44(3) of the Securities and Exchange Board of India (Listing Obligation and Disclosure Requirements) Regulations 2015, they will submit details regarding the Voting Results of Remote e-voting and Electronic Voting of the Resolutions passed in the Extra-ordinary General Meeting within two working days from the receipt of the report from the Scrutinizer.

The above information is a part of company’s filings submitted to BSE.
Peers
Company Name CMP
Sun Pharma. Inds. 1853.50
Dr. Reddys Labs. 1202.80
Cipla 1397.20
Lupin 2090.00
Zydus Lifesciences 1202.00
View more..